Patent 10016451 was granted and assigned to Anterios on July, 2018 by the United States Patent and Trademark Office.
The present invention provides nanoparticle compositions including one or more nucleic acids. The present invention achieves delivery (particularly transdermal delivery) of such nucleic acids without the need for nucleic acid modification, or for use of chemical or mechanical abrasion or disruption of skin.